Forced miR-142-3p expression drives proliferation, migration, and chemoresistance in lung cancer and hepatoma lines, whereas miR-142-3p knockdown or pharmacological DNMT1 inhibition restores CDH13 expression and sensitivity to apoptosis induction. Here, CDH13 is linked to lung carcinoma.